NCT03968510View on ClinicalTrials.gov

Swalqol in Primary Hyperparathyroidism

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

July 1, 2020

Study Completion Date

November 1, 2020

Conditions
Hyperparathyroidism
Interventions
PROCEDURE

parathyroidectomy

routine parathyroidectomy will be done for the treatment of adenoma

Trial Locations (1)

64100

Uşak University, Uşak

All Listed Sponsors
lead

Uşak University

OTHER

NCT03968510 - Swalqol in Primary Hyperparathyroidism | Biotech Hunter | Biotech Hunter